BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16054582)

  • 1. Current status of quality in Japanese clinical trials.
    Saito K; Kodama Y; Ono S; Mutoh M; Kawashima S; Fujimura A
    Contemp Clin Trials; 2005 Aug; 26(4):503-9. PubMed ID: 16054582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent changes in quality in Japanese clinical trials.
    Saito K; Kodama Y; Ono S; Fujimura A
    Ann Pharmacother; 2004 Jan; 38(1):151-5. PubMed ID: 14742810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of Japanese clinical trials estimated from GCP audit findings.
    Saito K; Kodama Y; Ono S; Maida C; Fujimura A; Miyamoto E
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):415-20. PubMed ID: 18793583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Japanese clinical trials estimated from good clinical practice audit findings.
    Saito K; Kodama Y; Ono S; Mutoh M; Kawashima S; Fujimura A
    Am J Ther; 2006; 13(2):127-33. PubMed ID: 16645429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Public GCP unit--experiences from the Aarhus University Hospital].
    Jørgensen A; Rønnow IL; Nexø E
    Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
    Ebi O
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quality of conduct in Japanese clinical trials: deficiencies found in GCP inspections.
    Ono S; Kodama Y; Nagao T; Toyoshima S
    Control Clin Trials; 2002 Feb; 23(1):29-41. PubMed ID: 11852162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Organization, administration, and performance of clinical studies].
    Bachner M; Steininger T; Gneist M
    Onkologie; 2008; 31 Suppl 2():3-6. PubMed ID: 18487861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In order to perform clinical trials efficiently in Japan--important issues in medical institutions raised by the GCP on-site review].
    Akiyama T; Furuta M; Yamada H
    Nihon Kokyuki Gakkai Zasshi; 2006 Aug; 44(8):541-9. PubMed ID: 16972610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
    Zon R; Meropol NJ; Catalano RB; Schilsky RL
    J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Report on the experience of clinical trials performed according to GCP].
    Lörinczi K
    Acta Pharm Hung; 1997 Jul; 67(4):137-9. PubMed ID: 9289941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of an anticancer drug in Japan based on a new clinical trial system].
    Nakashima H; Nakano S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):287-94. PubMed ID: 9492818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacy standards for clinical trials].
    Terkola R
    Onkologie; 2008; 31 Suppl 2():25-8. PubMed ID: 18487865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative method of evaluating quality of international clinical studies in China: Analysis of site visit reports of the Clinical Research Operations and Monitoring Center.
    Chang JJ; Xu J; Fan D
    Contemp Clin Trials; 2008 Sep; 29(5):654-62. PubMed ID: 18450522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting good clinical practices in the conduct of clinical trials: experiences in the Department of Veterans Affairs Cooperative Studies Program.
    Sather MR; Raisch DW; Haakenson CM; Buckelew JM; Feussner JR;
    Control Clin Trials; 2003 Oct; 24(5):570-84. PubMed ID: 14500054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infrastructure of cancer clinical trial cooperative groups in western countries].
    Fukuda H
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1144-51. PubMed ID: 10945009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GCP data quality for early clinical development.
    Rock EP; Molloy VJ; Humphrey JS
    Clin Cancer Res; 2010 Mar; 16(6):1756-63. PubMed ID: 20215550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.